The spinal muscular atrophy market is comprised of therapies and products that aid in treatment of spinal muscular atrophy condition characterized by degeneration of motor neurons in the spinal cord. Some key therapies include nusinersen injection, onasemnogene abeparvovec gene therapy and other supportive care products. Nusinersen works by modifying splicing of the SMN2 gene to incre... https://www.ukwebwire.com/sma-market-grows/